Literature DB >> 8008216

Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: an in situ hybridization study.

S Petanceska1, S Burke, S J Watson, L Devi.   

Abstract

The cysteine lysosomal proteases comprise a large family of highly conserved enzymes which are essential for intracellular protein turnover. These proteases are very efficient in their ability to degrade components of the extracellular matrix, and have been implicated in processes of cell growth, malignant transformation and inflammation. There is also a growing body of evidence for their involvement in the metabolism of the amyloid precursor protein. The production of insoluble beta A4 amyloid peptide is thought to be one of the key events that lead to the development of Alzheimer's pathology. To see the physiological role these enzymes play in the brain, we studied the relative abundance and distribution of the messenger RNAs for three lysosomal cysteine proteases, cathepsins B and L and cathepsin S, by in situ hybridization histochemistry in rat brain. All three enzymes are capable of degrading components of the extracellular matrix but they have different substrate preferences and resistances to neutral pH. We found that the mRNAs for cathepsins B, L, and S have different expression patterns in brain. Cathepsin B mRNA shows the highest level of expression. It has a wide distribution, and is preferentially expressed in neurons. The expression patterns of cathepsin B and cathepsin L mRNA overlap in many brain regions; in some areas they complement each other. Cathepsin B and L mRNAs are highly expressed in the choroid plexus, a structure that is instrumental in brain development. Both transcripts are also abundant in the neuropeptide synthesizing hypothalamic nuclei. Cathepsin S mRNA has wide expression pattern throughout brain, in grey and white matter. A great number of cells that express cathepsin S have microglial morphology. Regions that are known to contain the highest amounts of the amyloid precursor protein express highest levels of cathepsin B and cathepsin L mRNA. Also, all three transcripts are highly represented in regions that are most prone to degeneration in Alzheimer's disease. These results suggest a role for these lysosomal hydrolases released from degenerating cells in the development of Alzheimer's pathology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008216     DOI: 10.1016/0306-4522(94)90190-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  High level expression and crystallization of recombinant human cathepsin S.

Authors:  D Brömme; M E McGrath
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

2.  FACS purification of immunolabeled cell types from adult rat brain.

Authors:  Danielle Guez-Barber; Sanya Fanous; Brandon K Harvey; Yongqing Zhang; Elin Lehrmann; Kevin G Becker; Marina R Picciotto; Bruce T Hope
Journal:  J Neurosci Methods       Date:  2011-09-03       Impact factor: 2.390

3.  The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.

Authors:  Gregory Hook; Vivian Hook; Mark Kindy
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions.

Authors:  J P Liuzzo; S S Petanceska; D Moscatelli; L A Devi
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

5.  Inactivation of NSF ATPase Leads to Cathepsin B Release After Transient Cerebral Ischemia.

Authors:  Dong Yuan; Chunli Liu; Jiang Wu; Bingren Hu
Journal:  Transl Stroke Res       Date:  2017-10-17       Impact factor: 6.829

6.  Neuronal loss and brain atrophy in mice lacking cathepsins B and L.

Authors:  Ute Felbor; Benedikt Kessler; Walther Mothes; Hans H Goebel; Hidde L Ploegh; Roderick T Bronson; Bjorn R Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

Review 7.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

8.  Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.

Authors:  J S Munger; C Haass; C A Lemere; G P Shi; W S Wong; D B Teplow; D J Selkoe; H A Chapman
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

9.  The clinical significance of cathepsin S expression in human astrocytomas.

Authors:  Thomas Flannery; David Gibson; Menakshi Mirakhur; Stephen McQuaid; Caroline Greenan; Anne Trimble; Brian Walker; Derek McCormick; Patrick G Johnston
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 10.  Dysfunction of Membrane Trafficking Leads to Ischemia-Reperfusion Injury After Transient Cerebral Ischemia.

Authors:  Dong Yuan; Chunli Liu; Bingren Hu
Journal:  Transl Stroke Res       Date:  2017-10-11       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.